Kim DH, Min EJ, Kim B, Choi JY, et al. RECIST 1.1, mRECIST, and Choi criteria for evaluating treatment response and survival outcomes in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab. Eur Radiol 2024 Jul 30. doi: 10.1007/s00330-024-10986.
PMID: 39080067